AACE Annual Meeting 2026 On-Demand

AACE Annual Meeting 2026 On-Demand brings together clinical endocrinology topics from the April 22–24 meeting at Caesars Forum in Las Vegas. The program spans diabetes technology, obesity and nutrition, thyroid disease, bone and parathyroid disorders, cardiometabolic risk, and pituitary and adrenal care. Sessions also consider practical uses of AI, referral management and endocrine education. The MedicalAmboss package is listed as recorded videos with subtitles for self-paced study. The curriculum below retains the listed session titles, supporting topic lists and named lectureships, so you can see how the material is organized across the meeting’s clinical themes.

Package scope: Videos and subtitles are included; PDFs, PowerPoint files and presentation slides are not. The original meeting advertised more than 75 sessions, which is not a verified file count for this package. AACE’s June 1, 2026–April 30, 2027 on-demand activity and its credit arrangements refer to the publisher’s service; this purchase does not provide AACE enrollment, platform access, MOC or other accreditation benefits.

Learning Objectives

By the end of the educational activity, learners should be able to:

• Discuss recent scientific and clinical discoveries in endocrinology, diabetes, and metabolism.
• Apply newly acquired knowledge to diagnosis and clinical management to improve patient outcomes.
• Assess the potential applications of emerging scientific advances affecting endocrine practice.
• Educate patients regarding available clinical treatment options.
• Recognize new technologies and therapeutic approaches influencing endocrine care.
• Apply contemporary approaches to diabetes, obesity, thyroid, metabolic bone, pituitary, adrenal, and cardiometabolic disorders.

Bone and Parathyroid

CKD-Related Metabolic Bone Disease

• Calcium balance
• Phosphate regulation
• Vitamin D
• Parathyroid hormone
• Bone turnover
• Renal osteodystrophy

Hypoparathyroidism: Diagnosis and Management – What the Guidelines Tell Us

Topics may include:

• Calcium management
• Vitamin D therapy
• PTH replacement
• Biochemical monitoring
• Chronic complications
• Guideline-based management

Hormone Therapy in the Prevention and Treatment of Osteoporosis

Anabolic First or Bisphosphonate First? Rethinking the Initial Approach to Treatment

• Fracture risk
• Treatment sequencing
• Anabolic therapies
• Bisphosphonates
• Long-term skeletal outcomes

Nutrition and Skeletal Health

Rare Bone Disorders: Primer for Diagnosis and Treatment

DSN Year in Review – Bone

Diabetes & Diabetes Technology

AACE 2026 Algorithm for Management of Adults with Type 2 Diabetes

Clinical decision-making may incorporate:

• Glycemic control
• Cardiovascular disease
• Chronic kidney disease
• Obesity
• Hypoglycemia risk
• Weight management
• Medication selection
• Patient preferences

Global Perspectives on Diabetes and Obesity

Cell Therapies in T1DM – Are We Close to a Cure?

• Islet replacement
• Stem-cell-derived therapies
• Immune protection
• Insulin independence
• Future therapeutic possibilities

Continuous Ketone Monitoring

Insulin Pumps for Type 2 Diabetes

CGM for Gestational Diabetes

Perioperative Management of CGM and Automated Insulin Delivery Systems

• CGM
• Insulin pumps
• Automated insulin delivery
• Perioperative glucose monitoring
• Device safety

AI’s Transformation in Diabetes Care

• Glucose data interpretation
• Predictive analytics
• Personalized treatment
• Diabetes devices
• Clinical workflow
• Decision support

Atypical Diabetes: PTD and CFRD

Weekly Insulin – Pros and Cons

Early-Stage Type 1 Diabetes: Screening, Monitoring and Treatment

This was also the topic of the Alan J. Garber, MD, PhD, MACE Lectureship, presented by Linda DiMeglio, MD, MPH during the 2026 meeting.

Advances in Prediabetes and Diabetes Prevention

Thyroid

Nutrition and Thyroid Health

Updates to Thyroid Nodules and Cancer Guidelines

• Thyroid nodules
• Risk stratification
• Imaging
• Biopsy
• Molecular testing
• Thyroid cancer
• Surveillance
• Treatment

Iodine, Thyroid Autoimmunity, Goiter and Oncogenesis

Minimally Invasive Management of Thyroid Nodules

Optimal Thyroid Hormone Replacement in Thyroid Cancer

Challenging Benign and Malignant Thyroid Cases

Drug-Induced Thyroid Dysfunction

• Hypothyroidism
• Hyperthyroidism
• Thyroiditis
• Abnormal laboratory testing

DSN Year in Review – Thyroid

Deconstructing the TSH Feedback Loop

Integrating Deiodinase Biology into the Management of Hypothyroidism

Presented by Antonio C. Bianco, MD, PhD, this was the Kahn-Tan-Faiman Frontiers in Science and Endocrinology Lectureship at AACE 2026.

• TSH physiology
• Deiodinase biology
• T4-to-T3 conversion
• Individual variation in thyroid hormone metabolism
• Implications for hypothyroidism management

Cardiovascular, Cardiometabolic & Lipids

Lp(a): What Every Endocrinologist Needs to Know

• Measurement
• Risk assessment
• Interpretation
• Cardiovascular implications
• Emerging therapies

Cardiovascular Risk Management in Type 1 Diabetes

Cardiometabolic Risk in South Asians

MASLD and MASH

Topics may include:

• Obesity
• Diabetes
• Insulin resistance
• Fibrosis assessment
• Cardiometabolic risk
• Multidisciplinary management

Optimizing Dyslipidemia Management

Application of the AACE Algorithm to Patient Care

Multidisciplinary Management of MASLD and MASH

• Endocrinologists
• Hepatologists
• Primary care clinicians
• Obesity specialists
• Nutrition professionals

Pituitary, Gonad, Adrenal & Neuroendocrine

Functional Hypogonadism

Personalized Treatments for Acromegaly

Hyperaldosteronism Screening and Management

• Screening criteria
• Aldosterone-renin testing
• Confirmatory testing
• Imaging
• Adrenal venous sampling
• Medical treatment
• Surgical management

Evaluation of Suspected Pheochromocytoma

DSN Year in Review – PGAN

• Pituitary
• Gonadal
• Adrenal
• Neuroendocrine disorders

PCOS: An Evidence-Based Approach to Comprehensive Management in 2026

• Menstrual dysfunction
• Hyperandrogenism
• Fertility
• Metabolic disease
• Weight management
• Diabetes risk
• Cardiovascular risk

Pituitary Masses Requiring Surgery

Pre- and Postoperative Endocrine Considerations

The Indeterminate Adrenal Mass

Obesity & Nutrition

Should We Continue to Use BMI When Talking About Obesity?

The Do’s and Don’ts of Microdosing GLP-1 RA

Nutrition and Chronic Disease

• Obesity
• Diabetes
• Cardiovascular disease
• Metabolic health
• Chronic endocrine conditions

Menopause, Metabolism and Weight

GLP-1 Use in Type 1 Diabetes and Obesity

Pediatric Obesity

DSN Year in Review – Nutrition & Obesity

Exercise and Nutrition for Patients Taking GLP-1 RA/GIP Agents

• Nutrition
• Protein intake
• Exercise
• Lean mass
• Weight loss
• Treatment tolerance

Strategies to Decrease Sarcopenia

Obesity Management Across Solid Organ Transplantation

Professional Development & Artificial Intelligence

Triaging Endocrine Referrals

EHR Optimization

Making AI Work for You: Practical Applications in the Endocrine Clinic

Potential areas include:

• Documentation
• Decision support
• Patient education
• Data analysis
• Workflow automation
• Clinical efficiency

Advancing Endocrine Education

Graduated Responsibility and Precision Learning